July 9, 2026 — AccurKardia, Inc. and Wellysis have announced a multi-year agreement under which AccurKardia’s AccurECG ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
July 9, 2026 — Elucid recently announced first patient enrollment in AI-Predict, a retrospective, international ...
Primary care providers (PCPs) stand on the front lines of diagnosing clinically significant valvular heart disease (VHD) ...
June 29, 2026 — A new international expert consensus document refines and updates how heart failure is identified and ...
June 29, 2026 — Konica Minolta, Inc. has announced that a research group has developed a simple and rapid technique for ...
June 25, 2026 — Johnson & Johnson has announced the initiation of its Skyward investigational device exemption (IDE) ...
A physical exam and echocardiogram have been the traditional tools for diagnosing aortic stenosis. Yet many patients ...
June 9, 2026.— Pentixapharm Holding AG has announced that the U.S. Food and Drug Administration (FDA) has cleared its ...
June 2, 2026 — AccurKardia, Inc. has been granted US Patent No. 12,620,488 for the company's proprietary machine ...
May 28, 2026 — Coredio has announced that the U.S. Food and Drug Administration (FDA) has granted its Cardiac ...
May 26, 2026 — According to researchers in Europe, women are more likely to face delays in diagnosis of cardiovascular ...
May 10, 2026 — WhiteSwell has announced primary results from the DELTA-HF feasibility clinical trial evaluating the eLym ...
Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...
May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...
July 13, 2026